[1]
Maung, S.T., Bwa, A.H., Sein Win, S.T., Htar, S.S., Wint Han, K.A., Pwint Oo, M., Lwin, S.H., Than Hlaing, N.K. and Win, K.M. 2021. Efficacy of Fixed-dose Combination of Sofosbuvir and Ledipasvir (SOF/LDV) ± Ribavirin (RBV) in Patients (n=130) Infected with HCV Genotype 6 (Real World Myanmar Experience). Greater Mekong Subregion Medical Journal. 1, 1 (Jan. 2021), 1–10.